Supported content
Independently created content that is financially supported by our commercial partners. The Pharmaceutical Journal retains editorial responsibility.

Managing childhood eczema: a visual guide

Research has revealed concerns about using topical corticosteroids in children with eczema, both among parents and pharmacists, leading to suboptimal treatment that perpetuates the condition.
Article Supported By
Photo of a toddler with eczema on their face

Eczema also known as atopic dermatitis is characterised by relapsing episodes of skin inflammation and intense itching, resulting in a rash and dry skin lesions that can bleed, ooze and become infected. Eczema has two main pathological elements: impaired skin barrier function and immune dysfunction.

Register for free to keep on reading

Access two premium articles as a registered user.

Register

Already an RPS member or registered? Log in

Register for free to keep on reading

Access two premium articles as a registered user.

Register

Already an RPS member or registered? Log in

Register for free to keep on reading

Access two premium articles as a registered user.

Register

Already an RPS member or registered? Log in

Register for free to keep on reading

Access two premium articles as a registered user.

Register

Already an RPS member or registered? Log in

Last updated